Similar Papers

Paper Title
Journal
Date
Author
P-42 Fostemsavir plus doravirine for the treatment of heavily treatment-experienced (HTE) people with HIV (PWH) with multi-drug resistant (MDR) HIV-1 infection: 48 weeks results in a real-life setting
Pf Salvo ... G Baldin
Sexually Transmitted Infections | VOL. 100
Pf Salvo, et. al.Pf Salvo ... G Baldin
01 Jun 2024
IN2 - Long-Term Health Benefit of Ibalizumab In The Treatment of Adults with Multidrug-Resistant HIV-1 Infection
Aj Brogan ... S Lewis
Value in Health | VOL. 21
Aj Brogan, et. al.Aj Brogan ... S Lewis
01 May 2018
The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States.
Anita J Brogan ... Ashley E Davis
PharmacoEconomics | VOL. 39
Anita J Brogan, et. al.Anita J Brogan ... Ashley E Davis
03 Feb 2021
Ibalizumab: The First Monoclonal Antibody for the Treatment of HIV-1 Infection.
Elias B Chahine ... Spencer H Durham
Annals of Pharmacotherapy | VOL. 55
Elias B Chahine, et. al.Elias B Chahine ... Spencer H Durham
13 Jul 2020
View more papers

More From: Value in Health

Paper Title
Journal
Date
Author
Table of Contents
-
Value in Health | VOL. -
--
01 Jan 2025
A Value Set for the EQ-5D-5L for United Arab Emirates
Fatima Al Sayah ... Samer A Kharroubi
Value in Health | VOL. -
Fatima Al Sayah, et. al.Fatima Al Sayah ... Samer A Kharroubi
01 Jan 2025
Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations
Zixuan Jin ... Ka Keat Lim
Value in Health | VOL. -
Zixuan Jin, et. al.Zixuan Jin ... Ka Keat Lim
01 Jan 2025
Development and testing the psychometric properties of 20 bolt-on items for the EQ-5D-5L across 31 rare diseases
Richard Huan Xu ... Shuyang Zhang
Value in Health | VOL. -
Richard Huan Xu, et. al.Richard Huan Xu ... Shuyang Zhang
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.